
FDA Panel Endorses First Lower-cost Biotech Drug
Biotechnology News
WASHINGTON (AP) ? Federal health experts have unanimously endorsed a Novartis drug which is expected to become the first lower-cost copy of a biotech drug to reach the U.S. market.
Source